FdaApplication

BLA 761365

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAstellas Pharma US, Inc.
application_typeBLA
approval_date2024-10-18

Products (2)

ProductActive ingredientStrengthDosage form
VYLOYZOLBETUXIMAB-CLZB100MGFor Injection
VYLOY—300MGFor Injection

2 products